Aaron Jl Lynch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron Jl Lynch has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Colomer-Winter
Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
2 shared publications - José A. Lemos
Affiliation Department of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, United States of America
2 shared publications - Kristi L. Frank
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2 shared publications - Shannon P Baker
Philips Institute for Oral Health Research Virginia Commonwealth University Richmond VA USA
2 shared publications - Todd Kitten
Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Virginia, USA
2 shared publications Ana L Flores-Mireles
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
1 shared publication
Latest Publications
- Open Access
- 20 September 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (9) , e1007102
Manganese acquisition is essential for virulence of Enterococcus faecalis
Manganese (Mn) is an essential micronutrient that is not readily available to pathogens during infection due to an active host defense mechanism known as nutritional immunity. To overcome this nutrient restriction, bacteria utilize high-affinity transporters that allow them to compete with host metal-binding proteins. Despite the established role of Mn in bacterial pathogenesis, little is known about the relevance of Mn in the pathophysiology of E. faecalis. Here, we identified and characterized the major Mn acquisition systems of E. faecalis. We discovered that the ABC-type permease EfaCBA and two Nramp-type transporters, named MntH1 and MntH2, work collectively to promote cell growth under Mn-restricted conditions. The simultaneous inactivation of EfaCBA, MntH1 and MntH2 (ΔefaΔmntH1ΔmntH2 strain) led to drastic reductions (>95%) in cellular Mn content, severe growth defects in body fluids (serum and urine) ex vivo, significant loss of virulence in Galleria mellonella, and virtually complete loss of virulence in rabbit endocarditis and murine catheter-associated urinary tract infection (CAUTI) models. Despite the functional redundancy of EfaCBA, MntH1 and MntH2 under in vitro or ex vivo conditions and in the invertebrate model, dual inactivation of efaCBA and mntH2 (ΔefaΔmntH2 strain) was sufficient to prompt maximal sensitivity to calprotectin, a Mn- and Zn-chelating host antimicrobial protein, and for the loss of virulence in mammalian models. Interestingly, EfaCBA appears to play a prominent role during systemic infection, whereas MntH2 was more important during CAUTI. The different roles of EfaCBA and MntH2 in these sites could be attributed, at least in part, to the differential expression of efaA and mntH2 in cells isolated from hearts or from bladders. Collectively, this study demonstrates that Mn acquisition is essential for the pathogenesis of E. faecalis and validates Mn uptake systems as promising targets for the development of new antimicrobials. Enterococcus faecalis is a leading cause of hospital-acquired infections that are often difficult to treat due to their exceptional multidrug resistance. Manganese (Mn) is an essential micronutrient for bacterial pathogens during infection. To prevent infection, the host limits Mn bioavailability to invading bacteria in an active process known as nutritional immunity. To overcome this limitation, bacteria produce high-affinity Mn uptake systems to scavenge Mn from host tissues. Here, we identified the main Mn transporters of E. faecalis and show that, by working collectively, they are essential for growth of this opportunistic pathogen in Mn-restricted environments. Notably, the inability to acquire Mn during infection rendered E. faecalis virtually avirulent in different animal models, thereby revealing the essentiality of Mn acquisition to enterococcal pathogenesis. The results reported here highlight that bacterial Mn transport systems are promising targets for the development of novel antimicrobial therapies, which are expected to be particularly powerful to combat enterococcal infections.
- 20 September 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (9) , e1007102
Open AccessManganese acquisition is essential for virulence of Enterococcus faecalis
Manganese (Mn) is an essential micronutrient that is not readily available to pathogens during infection due to an active host defense mechanism known as nutritional immunity. To overcome this nutrient restriction, bacteria utilize high-affinity transporters that allow them to compete with host metal-binding proteins. Despite the established role of Mn in bacterial pathogenesis, little is known about the relevance of Mn in the pathophysiology of E. faecalis. Here, we identified and characterized the major Mn acquisition systems of E. faecalis. We discovered that the ABC-type permease EfaCBA and two Nramp-type transporters, named MntH1 and MntH2, work collectively to promote cell growth under Mn-restricted conditions. The simultaneous inactivation of EfaCBA, MntH1 and MntH2 (ΔefaΔmntH1ΔmntH2 strain) led to drastic reductions (>95%) in cellular Mn content, severe growth defects in body fluids (serum and urine) ex vivo, significant loss of virulence in Galleria mellonella, and virtually complete loss of virulence in rabbit endocarditis and murine catheter-associated urinary tract infection (CAUTI) models. Despite the functional redundancy of EfaCBA, MntH1 and MntH2 under in vitro or ex vivo conditions and in the invertebrate model, dual inactivation of efaCBA and mntH2 (ΔefaΔmntH2 strain) was sufficient to prompt maximal sensitivity to calprotectin, a Mn- and Zn-chelating host antimicrobial protein, and for the loss of virulence in mammalian models. Interestingly, EfaCBA appears to play a prominent role during systemic infection, whereas MntH2 was more important during CAUTI. The different roles of EfaCBA and MntH2 in these sites could be attributed, at least in part, to the differential expression of efaA and mntH2 in cells isolated from hearts or from bladders. Collectively, this study demonstrates that Mn acquisition is essential for the pathogenesis of E. faecalis and validates Mn uptake systems as promising targets for the development of new antimicrobials. Enterococcus faecalis is a leading cause of hospital-acquired infections that are often difficult to treat due to their exceptional multidrug resistance. Manganese (Mn) is an essential micronutrient for bacterial pathogens during infection. To prevent infection, the host limits Mn bioavailability to invading bacteria in an active process known as nutritional immunity. To overcome this limitation, bacteria produce high-affinity Mn uptake systems to scavenge Mn from host tissues. Here, we identified the main Mn transporters of E. faecalis and show that, by working collectively, they are essential for growth of this opportunistic pathogen in Mn-restricted environments. Notably, the inability to acquire Mn during infection rendered E. faecalis virtually avirulent in different animal models, thereby revealing the essentiality of Mn acquisition to enterococcal pathogenesis. The results reported here highlight that bacterial Mn transport systems are promising targets for the development of novel antimicrobial therapies, which are expected to be particularly powerful to combat enterococcal infections.
- Open Access
Manganese acquisition is essential for virulence of Enterococcus faecalis
Manganese (Mn) is an essential micronutrient that is not readily available to pathogens during infection due to an active host defense mechanism known as nutritional immunity. To overcome this nutrient restriction, bacteria utilize high-affinity transporters that allow them to compete with host metal-binding proteins. Despite the established role of Mn in bacterial pathogenesis, little is known about the relevance of Mn in the pathophysiology of E. faecalis . Here, we identified and characterized the major Mn acquisition systems of E. faecalis . We discovered that the ABC-type permease EfaCBA and two Nramp-type transporters, named MntH1 and MntH2, work collectively to promote cell growth under Mn-restricted conditions. The simultaneous inactivation of EfaCBA, MntH1 and MntH2 (Δ efa Δ mntH1 Δ mntH2 strain) led to drastic reductions (>95%) in intracellular Mn content, severe growth defects in body fluids (serum and urine) ex vivo , significant loss of virulence in Galleria mellonella , and virtually complete loss of virulence in rabbit endocarditis and murine catheter-associated urinary tract infection (CAUTI) models. Despite the functional redundancy of EfaCBA , MntH1 and MntH2 under in vitro or ex vivo conditions and in the invertebrate model, dual inactivation of efaCBA and mntH2 (Δ efa Δ mntH2 strain) was sufficient to prompt maximal sensitivity to calprotectin, a Mn- and Zn-chelating host antimicrobial protein, and for the loss of virulence in mammalian models. Interestingly, EfaCBA appears to play a prominent role during systemic infection, whereas MntH2 was more important during CAUTI. The different roles of EfaCBA and MntH2 in these sites could be attributed, at least in part, to the differential expression of efaA and mntH2 in cells isolated from hearts or from bladders. Collectively, this study demonstrates that Mn acquisition is essential for the pathogenesis of E. faecalis and validates Mn uptake systems as promising targets for the development of new antimicrobials.
Open AccessManganese acquisition is essential for virulence of Enterococcus faecalis
Manganese (Mn) is an essential micronutrient that is not readily available to pathogens during infection due to an active host defense mechanism known as nutritional immunity. To overcome this nutrient restriction, bacteria utilize high-affinity transporters that allow them to compete with host metal-binding proteins. Despite the established role of Mn in bacterial pathogenesis, little is known about the relevance of Mn in the pathophysiology of E. faecalis . Here, we identified and characterized the major Mn acquisition systems of E. faecalis . We discovered that the ABC-type permease EfaCBA and two Nramp-type transporters, named MntH1 and MntH2, work collectively to promote cell growth under Mn-restricted conditions. The simultaneous inactivation of EfaCBA, MntH1 and MntH2 (Δ efa Δ mntH1 Δ mntH2 strain) led to drastic reductions (>95%) in intracellular Mn content, severe growth defects in body fluids (serum and urine) ex vivo , significant loss of virulence in Galleria mellonella , and virtually complete loss of virulence in rabbit endocarditis and murine catheter-associated urinary tract infection (CAUTI) models. Despite the functional redundancy of EfaCBA , MntH1 and MntH2 under in vitro or ex vivo conditions and in the invertebrate model, dual inactivation of efaCBA and mntH2 (Δ efa Δ mntH2 strain) was sufficient to prompt maximal sensitivity to calprotectin, a Mn- and Zn-chelating host antimicrobial protein, and for the loss of virulence in mammalian models. Interestingly, EfaCBA appears to play a prominent role during systemic infection, whereas MntH2 was more important during CAUTI. The different roles of EfaCBA and MntH2 in these sites could be attributed, at least in part, to the differential expression of efaA and mntH2 in cells isolated from hearts or from bladders. Collectively, this study demonstrates that Mn acquisition is essential for the pathogenesis of E. faecalis and validates Mn uptake systems as promising targets for the development of new antimicrobials.